This beneficial spectrum extends from reducing elevated serum levels of hepatic enzymes, such as glutamyltransferase (GGT) and alanine aminotransferase (ALT) (which serve as key indicators of hepatic distress), to potentially preventing the development of liver cirrhosis, chronic hepatitis B and C infections, and nonalcoholic fatty liver disease (NAFLD) [33]. The gene discussed is GPT; the disease is cirrhosis of liver.